| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2020 | Additive-color multi-harmonic generation microscopy for simultaneous label-free differentiation of plaques, tangles, and neuronal axons | Chakraborty S.; Chen S.-T.; Hsiao Y.-T.; MING-JANG CHIU ; Sun C.-K. | Biomedical Optics Express | 11 | ||
| 2016 | Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): An open-label, randomised, phase 3 trial | Harbeck N.; CHIUN-SHENG HUANG ; Hurvitz S.; Yeh D.-C.; Shao Z.; Im S.-A.; Jung K.H.; Shen K.; Ro J.; Jassem J.; Zhang Q.; Im Y.-H.; Wojtukiewicz M.; Sun Q.; Chen S.-C.; Goeldner R.-G.; Uttenreuther-Fischer M.; Xu B.; Piccart-Gebhart M.; Krasnozhon D.; Tong Z.; Arora R.S.; Jacob L.A.; Staroslawska E.; Wang X.; Satya Suresh Attili V.; Mehta A.O.; Lee S.H.; Tseng M.-L.; Perera N.A.M.; Huizing M.; Melichar B.; Grigiene R.; Bharwani L.; Cortes J.; Garcia M.; Chirgwin J.; Baranau Y.; Ermakov N.; Li W.; Lin T.; Qin S.; Shen P.; Yang J.; Dohollou N.; Kerbrat P.; Uleer C.; Kristeleit H.; Nagarkar R.V.; Crown J.; Kelly C.; Kaufman B.; Ionta M.T.; Park K.H.; Farhat F.; Chin L.S.; Sufliarsky J.; Saenz J.A.G.; Begbie S.; Dittrich C.; Karchmit Y.; Awada A.; Bines J.; Rigo R.; Califaretti N.; Sridhar S.; Villa D.; Jiang Z.; Wang X.; Wu G.; Shu W.; Zheng H.; Delva R.; Pivot X.; Beckmann M.; Bischoff J.; Gerber B.; Maass N.; Richters L.; Schumacher C.; Jain M.M.; Indelli M.; Purkalne G.; Juozaityte E.; Erdkamp F.L.G.; Sanchez F.S.; Susko-Kazamowicz M.; Sousa S.; Mukhametshina G.; Shomova M.; Yap Y.S.; Beniak J.; Grasic C.; Demetriou G.; Maart K.; Pienaar R.; Rapoport B.; Chacon J.I.; Cao M.G.; Chen S.-T.; Chang H.-T.; Kaplan E.; Lawler W.; Carraro S.; Lerzo G.; Chan A.; Snyder R.; Noryk D.; Graas M.-P.; Aleixo S.; Caleffi M.; Franke F.; Hegg R.; Santi P.X.; Vinholes J.; Zereu M.; Ghedira S.; Poirier E.; Yelle L.; Yanez E.; Liu J.; Luo R.; Pecha V.; Petruzelka L.; Azim H.A.; Shamaa S.S.; Brain E.; Chauffert B.; Espie M.; Lortholary A.; Petit T.; Augustin D.; Barinoff J.; Fett W.; Hannig C.V.; Kurbacher C.M.; Otremba B.; Paepke S.; Adamson D.; Kristeleit H.; O'brien M.; Bhattacharyya G.S.; Krishnan S.; Mohan R.; Nag S.; Fried G.; Isacson R.; Nakayama T.; Kudaba I.; Luna G.A.; Dercksen M.W.; Honkoop A.; Tjan-Heijnen V.C.G.; van den Bosch J.; Palominos O.M.; Blasinska-Morawiec M.; Szczylik C.; Wysocki P.; Damasceno M.; Pais A.; Biakhov M.; Chovanec J.; Harris J.; Caranana V.; Lopez R.; Tusquets I.; Chang T.-W.; Liu M.-C.; Altundag K.; Gokmen E.; Avery T.; Chan D.; Kendall S.; Hetzel D.; Kass F.; Singh J.; The LUX-Breast 1 study group | The Lancet Oncology | 71 | 74 | |
| 2002 | Antibiotic usage in community-acquired infections in hospitals in Taiwan | Ho M.; Chang F.-Y.; Yin H.-C.; Ben R.-J.; LUAN-YIN CHANG ; Chen P.-Y.; Cheng S.-H.; Chen S.-T.; Huang F.-L.; Lin H.-C.; Lu D.C.T.; Wang N.-C.; Wang J.-T. | Journal of the Formosan Medical Association | 8 | ||
| 2002 | Antibiotic usage in community-acquired infections in hospitals in Taiwan | Ho M.; Chang F.-Y.; Yin H.-C.; Ben R.-J.; Chang L.-Y.; Chen P.-Y.; Cheng S.-H.; Chen S.-T.; Huang F.-L.; Lin H.-C.; Lu D.C.T.; Wang N.-C.; JANN-TAY WANG | Journal of the Formosan Medical Association | 8 | ||
| 2012 | Antidepressant use and the risk of upper gastrointestinal bleeding in psychiatric patients: A nationwide cohort study in Taiwan | Lee Y.-C.; Shau W.-Y.; CHIA-HSUIN CHANG ; Chen S.-T.; Lin M.-S.; Lai M.-S. | Journal of Clinical Psychopharmacology | 14 | 15 | |
| 2020 | Assessment of neuropathology of Alzheimer's disease brain with high-resolution, label-free multi-harmonic generation microscopy | Chakraborty S.; Wu P.-C.; Chen S.-T.; MING-JANG CHIU ; Sun C.-K. | Progress in Biomedical Optics and Imaging - Proceedings of SPIE | 0 | ||
| 2017 | Ataxia-telangiectasia mutated interactor regulates head and neck cancer metastasis via KRas expression | Li Y.-J.; Lai W.-T.; Chang C.-C.; Kuo M.Y.-P.; Deng Y.-T.; Yang C.-N.; Cheng S.-J.; Wu T.-S.; Chen S.-T.; BEEN-REN LIN | Oral Oncology | 1 | 4 | |
| 2017 | Ataxia-telangiectasia mutated interactor regulates head and neck cancer metastasis via KRas expression | Li Y.-J.; Lai W.-T.; Chang C.-C.; Kuo M.Y.-P.; Deng Y.-T.; Yang C.-N.; SHIH-JUNG CHENG ; Wu T.-S.; Chen S.-T.; Lin B.-R. | Oral Oncology | 4 | ||
| 2017 | Ataxia-telangiectasia mutated interactor regulates head and neck cancer metastasis via KRas expression | Li Y.-J.; Lai W.-T.; Chang C.-C.; YEN-PING KUO ; Deng Y.-T.; Yang C.-N.; Cheng S.-J.; Wu T.-S.; Chen S.-T.; Lin B.-R. | Oral Oncology | 4 | ||
| 2015 | B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway | Wu T.-S.; CHING-TING TAN ; Chang C.-C.; Lin B.-R.; Lai W.-T.; Chen S.-T.; Yen-Ping Kuo M.; Rau C.-L.; Jaw F.-S.; Chang H.-H. | Oncogene | 9 | 9 | |
| 2015 | B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway | Wu T.-S.; Tan C.-T.; Chang C.-C.; BEEN-REN LIN ; Lai W.-T.; Chen S.-T.; Yen-Ping Kuo M.; Rau C.-L.; Jaw F.-S.; Chang H.-H. | Oncogene | 9 | 9 | |
| 2015 | B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway | Wu T.-S.; Tan C.-T.; Chang C.-C.; Lin B.-R.; Lai W.-T.; Chen S.-T.; YEN-PING KUO ; Rau C.-L.; Jaw F.-S.; Chang H.-H. | Oncogene | 9 | ||
| 1990 | Bone changes in hyperthyroidism - A preliminary study | Chen S.-T.; Huang M.-J.; Juang J.-H.; Lin J.-D.; Huang B.-Y.; Huang H.-S.; KAI-YUAN TZEN | Chang Gung Medical Journal | 0 | ||
| 2005 | Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: A multigenic study on cancer susceptibility | Cheng T.-C.; Chen S.-T.; CHIUN-SHENG HUANG ; Fu Y.-P.; Yu J.-C.; Cheng C.-W.; Wu P.-E.; Shen C.-Y. | International Journal of Cancer | 116 | 107 | |
| 2006 | Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: A multigenic study on cancer susceptibility | Yu J.-C.; Hsu H.-M.; Chen S.-T.; Hsu G.-C.; CHIUN-SHENG HUANG ; Hou M.-F.; Fu Y.-P.; Cheng T.-C.; Wu P.-E.; Shen C.-Y. | Journal of Biomedical Science | 26 | 23 | |
| 2022 | C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma | Lin N.-Y.; Chen S.-T.; Chang H.-L.; Lu M.-Y.; Yang Y.-L.; Chou S.-W.; Lin D.-T.; Lin K.-H.; Jou S.-T.; Hsu W.-M.; Huang M.-C.; HSIU-HAO CHANG | Oncogenesis | 0 | ||
| 2022 | C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma | Lin N.-Y.; Chen S.-T.; Chang H.-L.; Lu M.-Y.; Yang Y.-L.; Chou S.-W.; Lin D.-T.; Lin K.-H.; SHIANN-TANG JOU ; Hsu W.-M.; Huang M.-C.; Chang H.-H. | Oncogenesis | 0 | ||
| 2021 | C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin αv | Kuo T.-C.; Wu M.-H.; Yang S.-H.; Chen S.-T.; Hsu T.-W.; Jhuang J.-Y.; Liao Y.-Y.; YU-WEN TIEN ; Huang M.-C. | Oncogene | 9 | 8 | |
| 2021 | C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin αv | Kuo T.-C.; MING-HSUN WU ; Yang S.-H.; Chen S.-T.; Hsu T.-W.; Jhuang J.-Y.; Liao Y.-Y.; Tien Y.-W.; Huang M.-C. | Oncogene | 8 | ||
| 2021 | C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin �\v | Kuo T.-C.; Wu M.-H.; SHIH-HUNG YANG ; Chen S.-T.; Hsu T.-W.; Jhuang J.-Y.; Liao Y.-Y.; Tien Y.-W.; Huang M.-C. | Oncogene | 9 | 8 |
